Educational only — not for clinical decisions
These explorers are simplified teaching aids built from published standards, research and this site’s pages. They are unvalidated and not reviewed. Do not use them to diagnose, treat, clear anyone to fly, or plan real operations. Everything runs in your browser; nothing you do is stored or sent.
Mission Timeline Explorer: When Each Risk Matters
Also: spaceflight risk timeline · mission phase hazards
RadiationIsolation & ConfinementDistance from EarthGravity FieldsHostile/Closed EnvironmentLaunch & AscentIn-flightEVA & Surface OpsEntry, Descent & LandingPostflight RecoveryLifetime SurveillanceLEO short-durationLEO long-durationCislunar / Lunar orbitLunar surfaceMars transit & surfacePublicStudentClinicianResearcherOperator / Spaceflight participantAstronaut & candidate
- Some risks peak in the first days (fluid shift, space motion sickness), some build with time in flight (radiation, bone and muscle loss, eye changes), and some peak after landing (fainting on standing, unsteadiness) [8][9][15][20]. ◆◆◆◆ High · F E
- Distance changes medical care: from lunar orbit a signal takes about 1.3 seconds, at Mars from a few minutes up to about 22 minutes (NASA: longest delays about 21–23 minutes), and there is no emergency evacuation during a Mars transit [2][6]. ◆◆◆◆ High · E
- A Mars orbital mission is about 2 to 3 years; NASA’s concept lists 6–9 months each way and 2–17 months in Mars orbit [2]. ◆◆◆◆ High · E
Proposed certainty (◆ High → ◇ Very low) and evidence-type tags: F flight · A analog · M model/animal · C computational · E expert/operational/standards. AI-proposed, pending reviewer confirmation. How to read the grades.
Mission timeline · launch → landing → recovery
Educational only — not for clinical decisionsLeft 70% of the chart: launch to landing. Right 30%: recovery on Earth. Darker = matters more (qualitative). The vertical line is the selected day.
Risks on the selected day
- Launch and landing forces
- Launch and landing expose crews to acceleration, vibration and impact. Landing-day medical teams are on standby. [7]
- Fluid shift (blood moves toward the head)
- In weightlessness, fluid shifts toward the head. Within about 2 days the body lowers circulating blood volume by around 15%. [8]
- Space motion sickness
- Spacewalks: decompression sickness
- Spacewalks (on the space station or the lunar surface) carry a risk of decompression sickness, prevented by breathing pure oxygen first. [11]
- Spacewalk days are shown as possible across the stay; real schedules vary by mission.
- Radiation exposure
- Radiation dose builds up for the whole flight. In low Earth orbit, Earth's magnetic field concentrates cosmic rays and solar-storm protons near the poles; beyond low Earth orbit, the vehicle is continually exposed to galactic cosmic rays. [12]
- A Mars round trip was estimated at about 660 millisieverts (mSv), above NASA's 600 mSv career limit. [13][14]
- Bone and muscle loss
- Eye and optic nerve changes
- Eye and optic nerve changes (spaceflight-associated neuro-ocular syndrome, SANS) occur on long-duration missions: about 70% of crew show at least one sign. Eyes are monitored after return. [17]
- Kidney stones
- Less urine and more urinary calcium raise stone risk in flight; in the year after flight, stone incidence may approach 2–7 times preflight. [18]
- Isolation, sleep and mood
- Isolation and confinement can affect sleep, mood and teamwork; behavioral health support continues throughout a mission. [19]
- Distance: signal delay and no quick return
- Far from Earth, messages are delayed and a fast trip home is not possible, so the crew must handle medical problems on their own. [2]
- Fainting on standing, unsteadiness
- Exams and reconditioning
Mission phases and where the durations come from
Short orbital flight (3 days)
Space station mission (6 months)
Lunar mission (example: 30 days at the Moon)
- Earth to lunar orbit: 4 days. About 3.5 days from launch to the lunar Gateway orbit in NASA's concept of operations (rounded up). [2]
- At the Moon (example stay): 30 days. Example length you can change. NASA's older levels of care treat 30 days or less beyond low Earth orbit as a short mission. [3]
- Return and landing: 5 days. About 5 days from lunar orbit to landing in NASA's concept of operations. [2]
- Signal delay: About 1.3 seconds one way from lunar orbit [2]
- Getting home: Return to definitive care takes days [2]
Mars orbital mission (about 2.5 years)
- Earth to lunar Gateway: 4 days. About 3.5 days (rounded up). [2]
- Transit to Mars: 228 days. NASA range 6–9 months; midpoint shown. [2]
- Mars orbit: 289 days. NASA range 2–17 months; midpoint shown. [2]
- Return to Gateway: 228 days. NASA range 6–9 months; midpoint shown. [2]
- Gateway to landing: 5 days. About 5 days. [2]
- Signal delay: A few minutes up to about 22 minutes one way at Mars (NASA: longest delays about 21–23 minutes), with possible blackouts of about 2 weeks [2][6]
- Getting home: No emergency evacuation during transit or Mars orbit [2]
How to use it
- Choose a mission profile.
- Set a launch date (Eastern Time). Dates along the timeline update.
- Drag the slider, or use the arrow keys, from launch to landing and through recovery. The chart highlights the risks that matter on that day, and the list below explains each one.
Mission lengths come from NASA documents (cited under each phase). The lunar surface stay is an example you can change.
Reading the bars
The shading is a qualitative teaching aid chosen by the editors: light means the risk is present, darker means it matters more. It is not a measured probability. Use the linked pages and the radiation dose estimator and recovery timeline tools for numbers.
Evidence profile
- Overall certainty
- ◆◆◆◇ Moderate (proposed)
- Evidence types
- F · Flight dataE · Expert / operational / standards
- Literature through
- 2026-10-14
- Validation
- Statements checked against the cited sources; the explorer is not clinically validated
- Credit
- Educational only; no CME or other credit
Requirements referenced 0
No NASA-STD-3001 requirement maps directly to this page. See the standards quick reference.
References 21
- Jones CW, Overbey EG, Lacombe J, et al. Molecular and physiological changes in the SpaceX Inspiration4 civilian crew. Nature. 2024;632:1155–1164. doi:10.1038/s41586-024-07648-x PMID:38862026 Peer-reviewed F
- NASA Human Research Program, Exploration Medical Capability Element. Medical System Concept of Operations for Mars Exploration Mission-11. HRP-48021, Baseline (April 2019). ntrs.nasa.gov/api/citations/20200001715/downloads/2020000171… NASA E
- NASA. NASA-STD-3001, Volume 1, Revision A (2014-07-30; historical). Section 4.1 Levels of Medical Care. standards.nasa.gov/sites/default/files/standards/NASA/B/Hist… Standard E
- NASA OCHMO. NASA Spaceflight Medical Selection, Recertification and Mission Evaluation Standards. OCHMO-STD-100.1A, Revision A (2024). ntrs.nasa.gov/citations/20240006194 Standard E
- NASA Human Research Program. Evidence Report: Risk of Adverse Health Outcomes and Decrements in Performance due to In-Flight Medical Conditions (2017). humanresearchroadmap.nasa.gov/evidence/reports/Medical.pdf NASA F
- NASA. Mars Communications Disruption and Delay. 2023 Moon to Mars Architecture Concept Review fact sheet (2024). www.nasa.gov/wp-content/uploads/2024/01/mars-communications-… NASA E
- NASA OCHMO. Crew Medical Support for Entry, Descent, and Landing. Technical Brief OCHMO-TB-051 (2026). www.nasa.gov/wp-content/uploads/2026/05/ochmo-tb-051-crew-me… NASA E
- NASA OCHMO. Orthostatic Intolerance. Technical Brief OCHMO-TB-019. www.nasa.gov/wp-content/uploads/2023/12/ochmo-tb-019-orthost… NASA E
- NASA OCHMO. Space Adaptation Sickness (SAS). Medical Technical Brief OCHMO-MTB-004 (2025). www.nasa.gov/wp-content/uploads/2025/09/ochmo-mtb-004-space-… NASA E
- NASA OCHMO. Spaceflight Experience and Medical Care. Technical Brief OCHMO-TB-033. www.nasa.gov/wp-content/uploads/2023/12/ochmo-tb-033-spacefl… NASA E
- NASA OCHMO. Decompression Sickness (DCS) Risk Mitigation. Technical Brief OCHMO-TB-037, Revision D (2026). www.nasa.gov/wp-content/uploads/2023/12/ochmo-tb-037-decompr… NASA E
- NASA Human Research Program. Evidence Report: Risk of Ionizing Radiation Carcinogenesis (2026). Table 3, Design Reference Mission categories. humanresearchroadmap.nasa.gov/evidence/reports/HRP-ER-CANCER… NASA C
- Zeitlin C, Hassler DM, Cucinotta FA, et al. Measurements of energetic particle radiation in transit to Mars on the Mars Science Laboratory. Science. 2013;340(6136):1080–1084. doi:10.1126/science.1235989 PMID:23723233 Peer-reviewed F
- NASA OCHMO. NASA-STD-3001, Volume 1: Crew Health, Revision C (2023). [V1 3004], [V1 3017], [V1 3018], [V1 4030]–[V1 4033] and Table 4.8-1. www.nasa.gov/wp-content/uploads/2023/11/nasa-std-3001-vol-1-… Standard E
- NASA Human Research Program. Evidence Report: Risk of Bone Fracture due to Spaceflight-induced Changes to Bone (July 18, 2024). humanresearchroadmap.nasa.gov/evidence/reports/Bone%20Fractu… NASA F
- Gabel L, Liphardt AM, Hulme PA, et al. Incomplete recovery of bone strength and trabecular microarchitecture at the distal tibia 1 year after return from long duration spaceflight. Sci Rep. 2022;12:9446. doi:10.1038/s41598-022-13461-1 PMID:35773442 Peer-reviewed F
- NASA OCHMO. Spaceflight Associated Neuro-ocular Syndrome (SANS). Medical Technical Brief OCHMO-MTB-001 (2024). www.nasa.gov/wp-content/uploads/2024/02/ochmo-mtb-001-sans.p… NASA E
- NASA Human Research Program. Evidence Report: Risk of Renal Stone Formation (2024). humanresearchroadmap.nasa.gov/evidence/other/2024%20Renal%20… NASA F
- NASA OCHMO. Behavioral Health and Performance. Technical Brief OCHMO-TB-016. www.nasa.gov/wp-content/uploads/2023/12/ochmo-tb-016-behavio… NASA E
- Lee SMC, Feiveson AH, Stein S, Stenger MB, Platts SH. Orthostatic intolerance after ISS and Space Shuttle missions. Aerosp Med Hum Perform. 2015;86(12 Suppl):A54–A67. doi:10.3357/AMHP.EC08.2015 PMID:26630196 Peer-reviewed F
- Mulavara AP, Feiveson AH, Fiedler J, et al. Locomotor function after long-duration space flight: effects and motor learning during recovery. Exp Brain Res. 2010;202(3):649–659. doi:10.1007/s00221-010-2171-0 PMID:20135100 Peer-reviewed F
Machine-checked on 2026-10-14: each URL was fetched, each DOI's title and year matched via Crossref, PubMed IDs matched to DOIs, and every number shown was checked against the source text (abstract, NASA document, regulation or official web page). Human verification against full text is still required before review.
Article info
- Authors
- Pending (AI-assisted)
- Reviewer
- AI-assisted clinical review (AI medical research assistant; no named human clinician)
- Last reviewed
- 2026-10-15
- Literature through
- 2026-10-14
- AI-assisted
- Yes (disclosed)
- COI
- Pending
- License
- CC BY-SA 4.0 (text); code MIT
- Privacy
- Runs entirely in your browser; no inputs stored or sent
- Use
- Educational only · not for clinical decisions · Disclaimer
- Cite this version
- Pending first edition
Educational use only · not medical advice · not for clinical decisions · Disclaimer · CC BY-SA 4.0